Prolia (denosumab) 60 mg/mL solution for injection, 1 mL pre-filled syringe (Amgen) Osteoporosis treatment. Drug delivery from Europe and beyond, within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Treatment of osteoporosis in postmenopausal women and in men with an increased risk of fractures. In postmenopausal women, the drug Prolia^® significantly reduces the risk of spinal fractures, non-spine fractures and peduncle fractures.

Treatment of bone mass loss in people with an advanced risk of fractures, as a means of terminating hormonal suppressive therapy in patients with cancer of the anterior pelvis (section “Pharmacodynamics”). In people with cervical cancer, who undergo hormone suppressive therapy, Prolia ^® significantly reduces the risk of spinal fractures.

Treatment of bone loss associated with chronic systemic glucocorticoid therapy in adult patients with an advanced risk of fractures

Dozuvannya

The recommended dose of denosumab is one 60 mg injection of the drug 1 time skin 6 months, which is injected at the hip, lives or the outer surface of the shoulder.